AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

STXS · AMEX · Medical - Instruments & Supplies

Stereotaxis

Builds magnetic-navigation robots and catheters for cardiac electrophysiology.

$1.45

After-hours close0.00 (0.00%)

At close$1.45(−1.36%)

Something off on this page? Send us feedback.

Profile

Stereotaxis, Inc.STXSHealth Care

Builds robotic magnetic-navigation systems and compatible catheters for cardiac electrophysiology, then earns from capital installations, disposable devices, software and service. Its integrated platform is expanding into mechanical robotics for cardiology and neurointervention.

Directs flexible, magnetically responsive catheters and guidewires inside blood vessels using external magnetic fields and computer controls. Genesis and GenesisX support electrophysiology mapping and ablation for arrhythmias, while R-One adds mechanical robotics for coronary and other endovascular procedures.

Sells capital equipment and installation alongside compatible disposable instruments, lab-control software and post-warranty service. Sales reach hospitals directly and through distributors, with recurring revenue tied to clinical use of the installed base; customer revenue is weighted outside the United States.

Relies on regulatory clearance that varies by device and geography, compatibility with third-party lab systems, and outsourced major system subassemblies; final assembly and inspection remain in-house.

Company facts

CEODavid L. Fischel

ListedAug 12, 2004

ExchangeAMEX

HeadquartersSt. Louis, MO

CountryUnited States

Employees131

CIK0001289340

ISINUS85916J4094

Key statistics

Market cap$142.0M

EPS (ttm)−$0.2471

P/E (ttm)−5.87

ROE-132.6%

P/B8.30

P/S4.72

Dividend yield—

Beta1.84vs XLV 0.35

Year to date −37.5% · Average volume (30d) 797.5K

Analysts

Price target, next 12 months$3.50+141.4%Median of 11 analysts · vs the Aug 28 close

ConsensusBuy11 of 11 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $1.45

High$3.50+141.4%

Median$3.50+141.4%

Low$3.50+141.4%

12 months agoNowIn 12 months

Latest analyst notes

Date	Firm	Action	Target
May 13, 2026	Piper Sandler	Target	$3.50

Earnings

EPS

Estimate−$0.05

ReportedDue Nov 10, 2026

Revenue

Estimate$9.6M

ReportedDue Nov 10, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 11, 2026Q2 FY26	−$0.05	−$0.05	0.0%	$8.4M	$7.7M	−8.1%	−4.11%
May 12, 2026Q1 FY26	−$0.04	−$0.03	+25.0%	$8.5M	$6.3M	−26.0%	−3.65%
Mar 9, 2026Q4 FY25	−$0.06	−$0.06	0.0%	$9.1M	$8.6M	−4.8%	−4.83%
Nov 11, 2025Q3 FY25	−$0.06	−$0.03	+50.0%	$9.2M	$7.5M	−19.2%	−14.74%

View details

Financial highlights

	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
Revenue	$7.5M	$8.8M	$7.5M	$8.6M	$6.3M	$7.7M
Gross profit	$4.1M	$4.6M	$4.1M	$4.3M	$3.8M	$4.5M
Operating income	−$5.9M	−$4.0M	−$6.6M	−$5.6M	−$5.2M	−$4.6M
Net income	−$5.8M	−$3.8M	−$6.5M	−$5.5M	−$5.9M	−$4.5M
Diluted EPS	−$0.07	−$0.05	−$0.07	−$0.06	−$0.06	−$0.05
Gross margin	54.4%	52.0%	54.9%	50.1%	60.3%	58.5%
Operating margin	-79.3%	-45.2%	-87.8%	-65.4%	-82.4%	-59.6%

Fiscal years (4-quarter sums)FY24 $26.9M · FY25 $32.4M

Revenue by product · Q2 FY26

Disposables Service And Accessories$6.2M · 81%

Systems$1.5M · 19%

Revenue by geography · FY25

Non-US$19.5M · 60%

United States$12.9M · 40%

Balance sheet, Jun 30, 2026Cash & short-term investments $10.5M · Total debt $5.2M · Total assets $55.6M · Shareholders' equity $17.5M

Dividends

No dividends on record.

Ownership

Institutions 44.13%Insiders —

Shares outstanding 97.93M · Float 69.58M · 71.0% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
Dafna Capital Management LLC	13.68M	13.97%	13F	Aug 14, 2026
Daniel Louis Kaufman	5.96M	5.90%	13G	Aug 19, 2026
BlackRock, Inc.	4.40M	4.49%	13F	Aug 7, 2026
Lagoda Investment Management, L.P.	4.12M	4.21%	13F	Aug 14, 2026
Vanguard Capital Management LLC	3.04M	3.11%	13F	Aug 13, 2026

Insider tradesForm 4

Nothing filed in the last 12 months.